562 related articles for article (PubMed ID: 28619077)
21. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and prognostic factors for Ewing-family tumors of the extremities.
Biswas B; Rastogi S; Khan SA; Mohanti BK; Sharma DN; Sharma MC; Mridha AR; Bakhshi S
J Bone Joint Surg Am; 2014 May; 96(10):841-9. PubMed ID: 24875025
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
[TBL] [Abstract][Full Text] [Related]
26. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
[TBL] [Abstract][Full Text] [Related]
27. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
[TBL] [Abstract][Full Text] [Related]
28. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.
Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM
Tumori; 2014; 100(4):452-8. PubMed ID: 25296596
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis.
Martin E; Radomski S; Harley EH
Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():138-142. PubMed ID: 30579068
[TBL] [Abstract][Full Text] [Related]
30. Timing of Local Therapy Affects Survival in Ewing Sarcoma.
Lin TA; Ludmir EB; Liao KP; McAleer MF; Grosshans DR; McGovern SL; Bishop AJ; Woodhouse KD; Paulino AC; Yeboa DN
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):127-136. PubMed ID: 30593906
[TBL] [Abstract][Full Text] [Related]
31. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma.
Paulino AC; Nguyen TX; Mai WY
Pediatr Blood Cancer; 2007 Apr; 48(4):423-9. PubMed ID: 16421909
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of local treatment strategies in non-metastatic Ewing sarcoma of bone.
Zhang WT; Zhang WW; He ZY; Sun JY; Zhang L; Xia Q; Wu SG
Expert Rev Anticancer Ther; 2018 May; 18(5):501-506. PubMed ID: 29537323
[TBL] [Abstract][Full Text] [Related]
33. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
Seitz G; Urla C; Sparber-Sauer M; Schuck A; Vokuhl C; Blank B; Klingebiel T; Kazanowska B; Fuchs J; Koscielniak E
Pediatr Blood Cancer; 2019 Mar; 66(3):e27537. PubMed ID: 30421578
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors.
Dunst J; Ahrens S; Paulussen M; Burdach S; Jürgens H
Strahlenther Onkol; 2001 Mar; 177(3):153-9. PubMed ID: 11285773
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U
Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy.
Kinsella TJ; Miser JS; Waller B; Venzon D; Glatstein E; Weaver-McClure L; Horowitz ME
Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):389-95. PubMed ID: 1995522
[TBL] [Abstract][Full Text] [Related]
37. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous and subcutaneous Ewing sarcoma.
Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
[TBL] [Abstract][Full Text] [Related]
39. Outcome of Ewing sarcoma in children and adolescents with Ewing sarcoma: a five-year survival from a single institution.
Zawitkowska-Klaczyńska J; Drabko K; Katski K; Wozniak M; Kowalczyk JR
Pediatr Hematol Oncol; 2004; 21(7):627-33. PubMed ID: 15626019
[TBL] [Abstract][Full Text] [Related]
40. [Survival of pediatric patients with Ewing sarcoma treated at Semmelweis University].
Geiszl Z; Kiss J; Szendrõi M; Vízkeleti J; Arató G; Sápi Z; Kriván G; Mohás A; Rényi I; Garami M; Hauser P
Magy Onkol; 2018 Dec; 62(4):230-236. PubMed ID: 30540865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
